Air purification company Aerus stated on Wednesday that its ActivePure Technology with Hydroxyl Blaster established a 99.98% surface kill rate of live SARS-CoV-2 virus in seven hours based on the testing data conducted by independent FDA compliant laboratory, MRIGlobal.
The company's ActivePure Technology is scientifically proven to destroy microscopic pathogens and contaminants on surfaces and in the air and is available in over 70 Aerus products, including the Aerus Medical Guardian cleared by the FDA as a Class II Medical Device 510(k).
According to the company, the Aerus Hydroxyl Blaster with ActivePure Technology is an affordable, mobile, plug-and-purify air purifier that works on interior aerosolized pathogens and surface contaminants.
In conjunction, the company is awaiting final approval from the US FDA for Emergency Use Authorization (EUA) for the Aerus Hydroxyl Blaster with ActivePure Technology for use in reducing SARS-CoV-2 surface pathogens. The results have a been submitted to the FDA-equivalent Canadian and European Union regulators as well. It expects to receive clearances in all jurisdictions.
Concurrently, the company is running independent laboratory tests to demonstrate the efficacy of ActivePure Technology on airborne SARS-CoV-2 virus for US FDA clearance.
AbbVie's ELAHERE receives full US FDA approval
Johnson & Johnson's OPSYNVI receives US FDA approval
Outlook Therapeutics receives positive CHMP opinion for ONS-5010 in wet AMD treatment
Human Immunology Biosciences receives ODD from FDA for felzartamab
Eton Pharmaceuticals acquires PKU GOLIKE, expanding rare disease portfolio
Vertex receives FDA clearance for VX-407 Investigational New Drug Application for ADPKD
Phanes Therapeutics receives FDA Fast Track designation for PT886
Bio-Thera Solutions signs new licensing agreement with SteinCares
FDA accepts resubmission of Citius Pharmaceuticals, Inc's BLA for LYMPHIR
GSK Plc reports positive Phase III Jemperli data for endometrial cancer
ImmVira receives FDA Fast Track designation for MVR-T3011 IT